E. de Wit
Infectious Diseases · Nature · 2006–2020
A researcher in the Science corpus: 14 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 149 citations into it
- Neurology — 25 citations into it
- Computational Theory and Mathematics — 5 citations into it
Whom E. de Wit trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Rolf Hilgenfeld
- S. Perlman
- Rachel L. Graham
- Susanna K. P. Lau
- Jason Netland
- J. Chan
- Christian Drosten
- C. Booth
Who trusts E. de Wit overall
Papers from E. de Wit's perspective
Ordered by how strongly the researchers E. de Wit trusts endorse each paper. Same corpus, a different order for every researcher.
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)
- Coronavirus as a possible cause of severe acute respiratory syndrome (The Lancet)
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation (Lancet. Infectious Diseases (Print))
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- Identification of a novel coronavirus in patients with severe acute respiratory syndrome. (New England Journal of Medicine)
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study (The Lancet)
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
- Angiotensin-converting enzyme 2 protects from severe acute lung failure (Nature)
Their papers
- SARS-CoV-2 cellular tropism (2020) — 653 citations
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 (2020) — 682 citations
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (2020) — 821 citations
- A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. (2020) — 1,273 citations
- Animal models for COVID-19 (2020) — 803 citations
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (2020) — 8,431 citations
- Respiratory disease in rhesus macaques inoculated with SARS-CoV-2 (2020) — 636 citations
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques (2020) — 830 citations
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection (2020) — 946 citations
- Mini viral RNAs act as innate immune agonists during influenza virus infection (2018) — 122 citations
- SARS and MERS: recent insights into emerging coronaviruses (2016) — 3,317 citations
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets (2012) — 1,628 citations
- Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets (2009) — 631 citations
- H5N1 Virus Attachment to Lower Respiratory Tract (2006) — 729 citations